APTX

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer
It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday!

Why Is Aptinyx (APTX) Stock Down 64% Today?

By William White, InvestorPlace Writer
Aptinyx (APTX) stock is taking a beating on Tuesday after the company revealed poor results from a Phase 2 clinical trial.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!

7 Biotech Stocks to Buy With Key Catalysts for April

By Shanthi Rexaline
Biotech stocks are very sensitive to some key catalysts such as the FDA decision date, aka PDUFA date, clinical readouts/presentations and Adcom meeting. The month of April will see some companies belonging to the sector seeing some of these make-or-break catalysts.

Aptinyx Stock Looks Promising If You’re Willing to Be Patient

By GS Early
When you're shopping for ground-floor biotech opportunities, it pays to be patient and diligent. APTX stock is looking good here.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer
We're at the midpoint of the week now and we're still going strong with a look at the biggest pre-market stock movers for Wednesday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer
Welcome back, traders! We're starting off another busy week of trading right with a look at the biggest pre-market stock movers for Monday.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

By William White, InvestorPlace Writer
We're taking a look at the biggest pre-market movers for Wednesday with a list of the 10 winners and losers on the stock market.

Aptinyx News: Why APTX Stock Is Skyrocketing Today

By Nick Clarkson, Web Editor
APTX stock is soaring on Tuesday after Aptinyx announced very positive results from its trial for a treatment for those with PTSD.